Recombinant human TSH: Background information and standard protocol

Essentials of Thyroid Cancer Management

Volumn , Issue , 2005, Pages 233-237

  Amdur, Robert J ^a   Mazzaferri, Ernest L ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78650852415     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-25714-4_30     Document Type: Chapter

References (3)

1. Drug evaluation information related to rhTSH can be found on the web at http://cpip.gsm.com and then enter "Thyrotropin" or "Thyrogen" in the search window
2. Haugen, BR, F Pacini, C Reiners, M Schlumberger, PW Ladenson, SI Sherman, DS Cooper, KE Graham, LE Braverman, MC Skarulis, TF Davies, LJ DeGroot, EL Mazzaferri, GH Daniels, DS Ross, M Luster, MH Samuels, DV Becker, HR Maxon III, RR Cavalieri, CA Spencer, K McEllin, BD Weintraub, and EC Ridgway. 1999. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 84:3877-3885
3. Vitale, G, GA Lupoli, A Ciccarelli, A Lucariello, MR Fittipaldi, F Fonderico, A Panico, and G Lupoli. 2003. Influence of body surface area on serum peak thyrotropin (TSH) levels after recombinant human TSH administration. J Clin Endocrinol Metab 88:1319-1322